Quick Answer
ESCALON MEDICAL CORP reported Stockholders Equity of $1.92 million for the year ending 2025.
- ESCALON MEDICAL CORP showed an increase of +5.8% in Stockholders Equity from 2024 to 2025.
- This data is from ESCALON MEDICAL CORP's annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $3.46 million | Q3 2013: $3.84 million | Q4 2013: $3.74 million | Q1 2014: $3.83 million | Q3 2014: $3.02 million | Q4 2014: $2.97 million | Q1 2015: $3.04 million | Q3 2015: $2.71 million | Q4 2015: $2.45 million | Q1 2016: $2.38 million | Q3 2016: $1.51 million | Q4 2016: $1.45 million | Q1 2017: $1.34 million | Q3 2017: $1.12 million | Q4 2017: $1.83 million | Q1 2018: $2.36 million | Q3 2018: $2.36 million | Q4 2018: $2.15 million | Q1 2019: $2.17 million | Q3 2019: $2.78 million | Q4 2019: $2.11 million | Q1 2020: $1.98 million | Q3 2020: $1.32 million | Q4 2020: $1.41 million | Q1 2021: $1.28 million | Q3 2021: $1.78 million | Q4 2021: $1.72 million | Q1 2022: $1.16 million | Q3 2022: $1.16 million | Q4 2022: $1.15 million | Q1 2023: $1.74 million | Q3 2023: $1.91 million | Q4 2023: $1.84 million | Q1 2024: $1.68 million | Q2 2024: $1.81 million | Q3 2024: $1.78 million | Q4 2024: $2.02 million | Q1 2025: $2.29 million | Q2 2025: $1.92 million | Q3 2025: $1.68 million | Q4 2025: $1.77 million.
- Over the full 16 years of available data (2010 to 2025), ESCALON MEDICAL CORP's Stockholders Equity has declined by 84.1%.
- Historical annual values: Fiscal year 2025: $1.92 million | Fiscal year 2024: $1.81 million | Fiscal year 2023: $1.93 million | Fiscal year 2022: $1.48 million | Fiscal year 2021: $1.46 million | Fiscal year 2020: $1.51 million | Fiscal year 2019: $2.16 million | Fiscal year 2018: $2.41 million | Fiscal year 2017: $1.18 million | Fiscal year 2016: $1.91 million | Fiscal year 2015: $2.99 million | Fiscal year 2014: $3.46 million | Fiscal year 2013: $3.83 million | Fiscal year 2012: $644.9 thousand | Fiscal year 2011: $6.19 million | Fiscal year 2010: $12.07 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: